Role of ¿1-pyrroline-5-carboxylate dehydrogenase supports mitochondrial metabolism and host-cell invasion of Trypanosoma cruzi

Proline is crucial for energizing critical events throughout the life cycle of Trypanosoma cruzi, the etiological agent of Chagas disease. The proline breakdown pathway consists of two oxidation steps, both of which produce reducing equivalents as follows: the conversion of proline to ¿1-pyrroline-5-carboxylate (P5C), and the subsequent conversion of P5C to glutamate. We have identified and characterized the ¿1-pyrroline-5-carboxy- late dehydrogenase from T. cruzi (TcP5CDH) and report here on how this enzyme contributes to a central metabolic pathway in this parasite. Size-exclusion chromatography, two-dimen- sional gel electrophoresis, and small angle x-ray scattering analysis of TcP5CDH revealed an oligomeric state composed of two subunits of six protomers. TcP5CDH was found to complement a yeast strain deficient in PUT2 activity, confirming the enzyme’s functional role; and the biochemical parameters (Km, kcat, and kcat/Km) of the recombinant TcP5CDH were determined, exhibiting values comparable with those from T. cruzi lysates. In addition, TcP5CDH exhibited mitochondrial staining during the main stages of the T. cruzi life cycle. mRNA and enzymatic activity levels indicated the up-regulation (6-fold change) of TcP5CDH during the infective stages of the parasite. The participation of P5C as an energy source was also demonstrated. Overall, we propose that this enzymatic step is crucial for the viability of both replicative and infective forms of T. cruzi

Analysis Of Anti-müllerian Hormone (amh) And Its Receptor (amhr2) Genes In Patients With Persistent Müllerian Duct Syndrome [pesquisa De Mutações Nos Genes Do Hormônio Antimülleriano (amh) E Do Seu Receptor (amhr2) Em Pacientes Com Síndrome De Persistência Dos Ductos Müllerianos]

Objective: To screen for mutations in AMH and AMHR2 genes in patients with persistent Müllerian duct syndrome (PMDS). Patients and method: Genomic DNA of eight patients with PMDS was obtained from peripheral blood leukocytes. Directed sequencing of the coding regions and the exon-intron boundaries of AMH and AMHR2 were performed. Results: The AMH mutations p.Arg95*, p.Arg123Trp, c.556-2A>G, and p.Arg502Leu were identified in five patients; and p.Gly323Ser and p.Arg407* in AMHR2 of two individuals. In silico analyses of the novel c.556-2A>G, p.Arg502Leu and p.Arg407* mutations predicted that they were harmful and were possible causes of the disease. Conclusion: A likely molecular etiology was found in the eight evaluated patients with PMDS. Four mutations in AMH and two in AMHR2 were identified. Three of them are novel mutations, c.556-2A>G, and p.Arg502Leu in AMH; and p.Gly323Ser in AMHR2. © ABE&M todos os direitos reservados.568473478Jost, A., Problems of fetal endocrinology: The gonadal and hypophyseal hormones (1953) Recent Prog Horm Res, 8, pp. 379-418Farikullah, J., Ehtisham, S., Nappo, S., Patel, L., Hennayake, S., Persistent Müllerian duct syndrome: Lessons learned from managing a series of eight patients over a 10-year period and review of literature regarding malignant risk from the Mullerian remnants (2012) BJU Int, , Epub 2012 Apr 30Rey, R., Picard, J.Y., Josso, N., Síndrome de Persistência dos Ductos de Müller (2010) Menino ou Menina? Distúrbios da Diferenciação do Sexo, pp. 279-295. , In: Guerra ATM, Guerra Júnior G, editors, 2. ed. RubioHutson, J.M., Davidson, P.M., Reece, L.A., Baker, M., Zhou, B., Failure of gubernacular development in the persistent Müllerian duct syndrome allows herniation of the testes (1994) Pediatr Surg Int, 9, pp. 544-546Abduljabbar, M., Taheini, K., Picard, J.Y., Cate, R.L., Josso, N., Mutations of the AMH Type II receptor in two extended families with persistent Müllerian duct syndrome: Lack of phenotype/genotype correlation (2012) Horm Res Paediatr, 77 (5), pp. 291-297Imbeaud, S., Faure, E., Lamarre, I., Mattei, M.G., Di Clemente, N., Tizard, R., Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor (1995) Nat Genet, 11 (4), pp. 382-388Cate, R.L., Mattaliano, R.J., Hession, C., Tizard, R., Farber, N.M., Cheung, A., Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells (1986) Cell, 45 (5), pp. 685-698Josso, N., Di Clemente, N., TGF-beta family members and gonadal development (1999) Trends Endocrinol Metab, 10 (6), pp. 216-222Josso, N., Belville, C., Di Clemente, N., Picard, J.Y., AMH and AMH receptor defects in persistent Müllerian duct syndrome (2005) Hum Reprod Update, 11 (4), pp. 351-356Menabo, S., Balsamo, A., Nicoletti, A., Gennari, M., Pirazzoli, P., Cicognani, A., Three novel AMH gene mutations in a patient with persistent Müllerian duct syndrome and normal AMH serum dosage (2008) Horm Res, 70 (2), pp. 124-128van der Zwan, Y.G., Bruggenwirth, H.T., Drop, S.L., Wolffenbuttel, K.P., Madern, G.C., Looijenga, L.H., A novel AMH missense mutation in a patient with persistent Müllerian duct syndrome (2012) Sex Dev, , Epub 2012 Jul 11Baarends, W.M., van Helmond, M.J., Post, M., van der Schoot, P.J., Hoogerbrugge, J.W., de Winter, J.P., A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct (1994) Development, 120 (1), pp. 189-197Di Clemente, N., Wilson, C., Faure, E., Boussin, L., Carmillo, P., Tizard, R., Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone (1994) Mol Endocrinol, 8 (8), pp. 1006-1020Belville, C., Marechal, J.D., Pennetier, S., Carmillo, P., Masgrau, L., Messika-Zeitoun, L., Natural mutations of the anti-Müllerian hormone type II receptor found in persistent Müllerian duct syndrome affect ligand binding, signal transduction and cellular transport (2009) Hum Mol Genet, 18 (16), pp. 3002-3013Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells (1988) Nucleic Acids Res, 16 (3), p. 1215Imbeaud, S., Carre-Eusebe, D., Rey, R., Belville, C., Josso, N., Picard, J.Y., Molecular genetics of the persistent Müllerian duct syndrome: A study of 19 families (1994) Hum Mol Genet, 3 (1), pp. 125-131Josso, N., Picard, J.Y., Rey, R., Di Clemente, N., Testicular anti-Müllerian hormone: History, genetics, regulation and clinical applications (2006) Pediatr Endocrinol Rev, 3 (4), pp. 347-358Rey, R.A., Codner, E., Iniguez, G., Bedecarras, P., Trigo, R., Okuma, C., Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias (2005) J Clin Endocrinol Metab, 90 (11), pp. 6035-6040Imbeaud, S., Belville, C., Messika-Zeitoun, L., Rey, R., Di Clemente, N., Josso, N., A 27 base-pair deletion of the anti-Müllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome (1996) Hum Mol Genet, 5 (9), pp. 1269-127